Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report.
Johanson CE, Balster RL, Henningfield JE, Schuster CR, Anthony JC, Barthwell AG, Coleman JJ, Dart RC, Gorodetzky CW, O'Keeffe C, Sellers EM, Vocci F, Walsh SL. Johanson CE, et al. Among authors: walsh sl. Drug Alcohol Depend. 2009 Dec 1;105 Suppl 1(Suppl 1):S65-71. doi: 10.1016/j.drugalcdep.2009.08.006. Epub 2009 Sep 23. Drug Alcohol Depend. 2009. PMID: 19783383 Free PMC article.
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations.
Comer SD, Zacny JP, Dworkin RH, Turk DC, Bigelow GE, Foltin RW, Jasinski DR, Sellers EM, Adams EH, Balster R, Burke LB, Cerny I, Colucci RD, Cone E, Cowan P, Farrar JT, Haddox DJ, Haythornthwaite JA, Hertz S, Jay GW, Johanson CE, Junor R, Katz NP, Klein M, Kopecky EA, Leiderman DB, McDermott MP, O'Brien C, O'Connor AB, Palmer PP, Raja SN, Rappaport BA, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Sokolowska M, Stauffer JW, Walsh SL. Comer SD, et al. Among authors: walsh sl. Pain. 2012 Dec;153(12):2315-2324. doi: 10.1016/j.pain.2012.07.035. Epub 2012 Sep 19. Pain. 2012. PMID: 22998781 Free PMC article.
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.
O'Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O'Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin RW, Haddox DJ, Hertz S, Jay GW, Junor R, Kopecky EA, Leiderman DB, McDermott MP, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP. O'Connor AB, et al. Among authors: walsh sl. Pain. 2013 Nov;154(11):2324-2334. doi: 10.1016/j.pain.2013.06.035. Pain. 2013. PMID: 24148704 Review.
A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal.
Gorodetzky CW, Walsh SL, Martin PR, Saxon AJ, Gullo KL, Biswas K. Gorodetzky CW, et al. Among authors: walsh sl. Drug Alcohol Depend. 2017 Jul 1;176:79-88. doi: 10.1016/j.drugalcdep.2017.02.020. Epub 2017 May 10. Drug Alcohol Depend. 2017. PMID: 28527421 Free article. Clinical Trial.
282 results